U.S. Nootropics Market Size & Outlook, 2021-2030
U.S. nootropics market, 2018-2030 (US$M)
Related Markets
U.S. nootropics market highlights
- The U.S. nootropics market generated a revenue of USD 1,171.2 million in 2021 and is expected to reach USD 3,698.6 million by 2030.
- The U.S. market is expected to grow at a CAGR of 13.6% from 2022 to 2030.
- In terms of segment, capsules/tablets was the largest revenue generating form in 2021.
- Drinks is the most lucrative form segment registering the fastest growth during the forecast period.
Nootropics market data book summary
| Market revenue in 2021 | USD 1,171.2 million |
| Market revenue in 2030 | USD 3,698.6 million |
| Growth rate | 13.6% (CAGR from 2021 to 2030) |
| Largest segment | Capsules/tablets |
| Fastest growing segment | Drinks |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Capsules/Tablets, Powder, Drinks |
| Key market players worldwide | Reckitt Benckiser Group PLC, Mental Mojo, Noocube, Mind Lab, truBrain, Nooflux, Zhou Nutrition, Kimera Koffee |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.2% of the global nootropics market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. nootropics market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 3,698.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nootropics Market Scope
Nootropics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. nootropics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nootropics market will help companies and investors design strategic landscapes.
Capsules/tablets was the largest segment with a revenue share of 46.9% in 2021. Horizon Databook has segmented the U.S. nootropics market based on capsules/tablets, powder, drinks covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounted for a major share of the overall North America nootropics market in 2022. As per one of the studies published by the National Center for Biotechnology Information, factors such as continuous stress, lack of sleep, fast-paced lifestyle, and long working hours are expected to affect the quality of life of individuals.
Especially of those in the U.S., which, in turn, is anticipated to propel the demand for the product among the consumers in the country. Nootropics are often prescribed for patients with ADHD, Alzheimer's, and Parkinson’s as these are cognitive enhancers and are used to boost brain health.
ADHD is a complex neurological condition, and its treatment typically involves evidence-based approaches such as behavioral therapy, psychoeducation, and medication. Nootropics are widely used to control neurotransmitters in the brain.
Reasons to subscribe to U.S. nootropics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. nootropics market databook
-
Our clientele includes a mix of nootropics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. nootropics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. nootropics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. nootropics market size, by form, 2018-2030 (US$M)
U.S. Nootropics Market Outlook Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
